Insider Holders & Insider Ownership - ANI PHARMACEUTICALS INC (ANIP)

List of insiders holdings for ANI PHARMACEUTICALS INC:
  1. Shares directly owned by the insider.
  2. Shares indirectly owned by the insider.
  3. Total shares owned by the insider (sum of shares directly and indirectly owned).
  4. Total market value if available.
  5. Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
#Insider Holder NameReport
Date Time
Shares Owned
Directly
Indirectly
Total
Shares Owned
Filing
1MERIDIAN VENTURE PARTNERS II LP
Meridian Venture Partners II GP L.P.
Meridian Venture Partners II Co.
Brown Robert E. JR
10% Owner
2025-03-13 20:50:291,184,570
0
1,184,570Form 13D
2SIMES STEPHEN M
Vice Chairman, President & CEO
2012-01-27 16:29:26800,000
202,267
1,002,267Form 4
3Shanmugam Muthusamy
HEAD OF R&D, COO-NOVITIUM OPS
2025-02-18 20:19:5892,588
637,620
730,208Form 4
4EDELMAN JOSEPH
PERCEPTIVE LIFE SCIENCES MASTER FUND LTD
PERCEPTIVE ADVISORS LLC
Cho Michael
10% Owner
2004-12-13 16:48:36709,819
0
709,819Form 13G
5EDELMAN JOSEPH
PERCEPTIVE LIFE SCIENCES MASTER FUND LTD
PERCEPTIVE ADVISORS LLC
10% Owner
2004-12-13 16:48:36709,819
0
709,819Form 13G
6Lalwani Nikhil
PRESIDENT & CEO
2025-03-25 16:47:48468,179
0
468,179Form 4
7MARSHBANKS TRACY
Director
2018-05-16 16:22:180
349,934
349,934Form 4
8DONENBERG PHILIP B
Sr VP of Finance, CFO, Secy
2012-01-27 16:33:48329,322
0
329,322Form 4
9RAYNOR DANIEL
Director
2018-03-19 16:54:290
289,003
289,003Form 4
10Gassert Chad
SVP - CORP. DEV. & STRATEGY
2025-02-18 20:14:0573,615
193,226
266,841Form 4
11PRZYBYL ARTHUR
President and CEO
2020-04-08 17:54:20190,309
0
190,309Form 4
12CAREY STEPHEN P.
SVP & CFO
2025-03-25 16:44:49180,863
0
180,863Form 4
13Snabes Michael C
Sr. VP of Medical Affairs
2012-01-27 16:37:45165,000
0
165,000Form 4
14LEHMAN LEAH M
VP, Product Development
2005-08-25 15:16:38150,000
0
150,000Form 4/A
15Marken James G.
SVP OPS & PROD DEV
2024-06-11 16:51:43117,829
0
117,829Form 4
16SHERWIN STEPHEN A
Director
2012-03-30 17:27:49111,760
0
111,760Form 4
17Mutz Christopher
HEAD OF RARE DISEASE
2025-03-14 17:22:35111,317
0
111,317Form 4
18Gutwerg Ori
SVP, GENERICS
2025-03-14 17:19:4690,778
0
90,778Form 4
19Schrepfer Robert W
SVP - NEW BUS DEV & SPEC SALES
2021-03-29 20:11:2387,477
0
87,477Form 4
20SULLIVAN LOUIS W
Director
2012-03-30 17:38:2282,898
0
82,898Form 4
21Cook Meredith
SR. VP, GENERAL COUNSEL & SEC.
2025-04-14 16:17:1180,145
0
80,145Form 4
22Jamnick Robert J.
VP, Quality & Product Develop.
2014-05-27 16:38:1177,701
0
77,701Form 4
23Walsh Patrick D
Director
2024-05-23 20:03:5374,712
0
74,712Form 4
24HO ANGELA
Director
2004-03-22 15:48:2972,137
0
72,137Form 4
25Davis Krista
SVP, CHIEF HR OFFICER
2025-03-20 16:14:0064,659
0
64,659Form 4
26Arnold Charlotte C.
Vice President and CFO
2016-04-11 19:10:1662,298
0
62,298Form 4
27HAUGHEY THOMAS
Director
2024-05-23 19:45:4751,526
0
51,526Form 4
28ROSENOW EDWARD C III
Director
2012-03-30 17:31:0145,540
0
45,540Form 4
29Rowland Thomas Andrew
SVP, HEAD - ESTABLISHED BRANDS
2025-03-04 17:15:0445,465
0
45,465Form 4
30KJAER PETER
Director
2010-04-02 16:26:5144,425
0
44,425Form 4
31Thoma Jeanne
Director
2024-05-23 20:02:1840,609
0
40,609Form 4
32NASH DAVID
Director
2023-05-24 16:31:1338,561
0
38,561Form 4
33Pera Antonio R
Director
2024-05-23 19:58:0331,037
0
31,037Form 4
34POTTS JOHN T JR
Director
2012-03-30 17:34:4127,657
2,924
30,581Form 4
35MANGANO ROSS J
Director
2014-09-16 16:40:5726,914
0
26,914Form 4
36BELL STEVEN J
VP Research & Pre-Clinical Dev
2005-08-25 15:32:2725,000
0
25,000Form 4/A
37TANNENBAUM RENEE P
Director
2024-05-23 19:59:4022,621
0
22,621Form 4
38Penn Thomas A.
Director
2019-04-01 16:00:2116,710
0
16,710Form 4
39HOLUBOW FRED
Director
2018-03-22 17:00:3516,144
0
16,144Form 4
40Leonard Matthew J
Director
2024-05-23 19:54:1311,993
0
11,993Form 4
41LANKAU PETER A
Director
2016-04-11 18:58:164,500
0
4,500Form 4
42MORGENSTERN VICTOR A
Director
2007-06-14 16:53:130
0
0Form 4